Evidence map›Paper›PMID 42146625›Full record

ArticlebioRxiv : the preprint server for biology2026

Kuan-Hung Lin, Amy Lam, Samuel van Ooijen, Madeline Maier, Gracia Kassis, Regan Ellis, Kathleen Messemer, Jennifer Martin, Ramzi Khairallah, Amy Wagers

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kuan-Hung LinDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA.
Amy LamDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA.
Samuel van OoijenDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA.
Madeline MaierDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA.
Gracia KassisDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA.
Regan EllisDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA.
Kathleen MessemerDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA.
Jennifer MartinMyologica, LLC, New Market, MD, USA.
Ramzi KhairallahMyologica, LLC, New Market, MD, USA.
Amy WagersDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA.

Funding

Regulation and Function of Growth Differentiation Factor 11 During Development and AgingR01AG048917 · NIA · HARVARD UNIVERSITY · PI WAGERS, AMY JO · 2016 to 2020
$2.8M
Regulation and function of Growth Differentiation Factor 11 during development and agingR56AG048917 · NIA · HARVARD UNIVERSITY · PI WAGERS, AMY JO · 2015 to 2015
$338k
NIA NIH HHS R01 AG048917NIA NIH HHS R56 AG048917
6 · The paper itself

Abstract

Duchenne muscular dystrophy (DMD) is the most common, lethal X-linked neuromuscular disorder of childhood and is caused by mutations in the

Identifiers

PMID42146625
PMCPMC13174644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.